Jove
Visualize
Contact Us

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Fingerprinting on Synthetic Alloys for Medulloblastoma Diagnosis and Radiotherapy Evaluation.

Advanced materials (Deerfield Beach, Fla.)·2020
Same author

FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling.

Cell death & disease·2020
Same author

Effect of monochromatic light on the temporal expression of <i>N-acetyltransferase</i> in chick pineal gland.

Chronobiology international·2020
Same author

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types.

Frontiers in pharmacology·2020
Same author

A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Role of melatonin in intestinal mucosal injury induced by restraint stress in mice.

Pharmaceutical biology·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 30, 2026

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
08:06

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Published on: August 4, 2017

11.8K

Optimizing adipose-derived stem cell therapy for diabetic foot ulcers.

Jing Cao1, Zi-Chao Liu1, Wen-Qiang An1

  • 1Department of Research and Development, Beijing AegleStem Therapeutics Co., Ltd, Beijing 102600, China.

World Journal of Diabetes
|November 24, 2025
PubMed
Summary

Adipose-derived mesenchymal stem cells (ADSCs) significantly improve diabetic foot ulcer (DFU) healing by promoting blood vessel growth and reducing inflammation. Subcutaneous injection into the foot is the most effective delivery method for these stem cells in DFU treatment.

Keywords:
Adipose-derived stem cellDiabetic foot ulcerDose-response relationshipNotch signaling pathwayPhosphatidylinositol 3-kinase

More Related Videos

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.6K
Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
04:53

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

Published on: January 12, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 30, 2026

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
08:06

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Published on: August 4, 2017

11.8K
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.6K
Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
04:53

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

Published on: January 12, 2024

1.4K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Therapy
  • Diabetic Complications Research

Background:

  • Diabetic foot ulcers (DFUs) are a major cause of lower limb amputation due to impaired wound healing.
  • Adipose-derived mesenchymal stem cells (ADSCs) show promise for DFU treatment due to their regenerative properties.
  • Limited understanding exists regarding the molecular mechanisms of ADSCs in DFU healing.

Purpose of the Study:

  • To determine the dose-response relationship of ADSCs for DFU healing.
  • To identify the optimal administration route and assess the persistence of ADSCs in DFU models.
  • To elucidate the molecular mechanisms by which ADSCs promote DFU healing.

Main Methods:

  • Human ADSCs were isolated, cultured, and characterized.
  • A DFU mouse model was used to evaluate dose-dependent effects and persistence of subcutaneously or intramuscularly administered ADSCs.
  • Wound healing, angiogenesis, inflammation, and collagen deposition were assessed; in vitro studies explored molecular mechanisms.

Main Results:

  • ADSC treatment significantly improved wound closure, angiogenesis, and tissue regeneration while modulating inflammation in DFU models.
  • Subcutaneous injection of 5 × 10^5 ADSCs into the foot demonstrated optimal therapeutic efficacy and prolonged retention.
  • ADSCs promote healing via PI3K/VEGF signaling for angiogenesis and Notch signaling for anti-inflammation and regeneration.

Conclusions:

  • ADSCs are effective in promoting diabetic foot ulcer healing.
  • ADSC-based therapy holds significant clinical potential for chronic non-healing diabetic wounds.
  • This study provides a basis for optimizing ADSC therapies for DFUs.